American Freedom Liberty 7 with MVA (Wells Fargo) review

It depends almost entirely on how you access it. For Wells Fargo clients, this is a good annuity — the carrier pedigree, 7-year cap lock feature, and income rider quality are all above-average for this product tier. For everyone else, it is not an option. Within those constraints, the accumulation mechanics are solid and the Income Ascender rider is competitive. The MVA is a real consideration if there is any chance you will need funds beyond the 10% free-withdrawal window during the surrender period.

The clearest reason is the combination of A++ carrier strength and the 7-year cap lock strategy. Most FIAs reset crediting terms annually, leaving buyers exposed to rate drops after year one. The Liberty 7's cap lock option — available at contract issue only — lets you fix the cap on selected strategies for the entire surrender period. For a buyer who values predictability and trusts the MassMutual Ascend relationship, that certainty has real value. A secondary reason: the Income Ascender rider's 9% simple roll-up on the benefit base is meaningful if the goal is eventual guaranteed withdrawals.

I think this product is best for a pre-retiree or retiree in their 50s to mid-70s who is already working with a Wells Fargo financial advisor, has $25,000 or more in non-emergency savings to commit for seven years, and wants principal protection paired with structured growth potential. It suits someone who appreciates the option to add a guaranteed income stream later without being required to pay for that rider upfront. It is less suited for someone who prioritizes access to funds, needs short-term liquidity, shops outside the Wells Fargo channel, or wants to stack both an income rider and an enhanced death benefit (those two riders are mutually exclusive here).

You are buying a principal-protected insurance contract issued by MassMutual Ascend Life Insurance Company — a subsidiary of Massachusetts Mutual Life, one of the oldest and most financially sound insurance companies in the country. Your premium is not invested in the stock market. Instead, MassMutual Ascend uses the interest it earns to purchase options tied to index performance, which determines how much interest, if any, gets credited to your account. The indices — S&P 500, First Trust Barclays Edge, iShares MSCI EAFE, and iShares U.S. Real Estate — are reference benchmarks only. You do not own shares, you do not receive dividends, and you cannot lose principal to market movements. The trade-off is that your upside is capped.

The Liberty 7 offers three ways to earn interest: annual point-to-point with a cap (resets each contract year), annual point-to-point with a 7-year cap lock (the cap is guaranteed for all seven years, selected once at issue), and a declared fixed account rate. Rate banding applies — contracts below $100,000 earn slightly lower caps and fixed rates than contracts at or above $100,000.

The 7-year cap lock is the headline differentiator. On the S&P 500, the locked cap as of the brochure date was 8.50% (low band) or 8.85% (high band). On the First Trust Barclays Edge Index — a risk-managed, rules-based index — the locked cap was 13.50% or 13.85%. The lock applies only to strategies selected in contract year one and cannot be changed once set. The practical benefit: if market interest rates fall after you issue the contract, your crediting ceiling does not drop with them.

There is also a bailout provision: if any one-year indexed strategy cap renews below 3.00%, you may surrender penalty-free within 30 days. That floor provides a measure of protection even for the annually-resetting strategies.

The optional Income Ascender — a Guaranteed Lifetime Withdrawal Benefit rider — is the secondary feature worth examining. At a current fee of 1.10% annually (with a maximum of 2.50%), it builds a benefit base separate from your account value. That benefit base earns 9% simple interest per year for up to 10 years, subject to a cap of 250% of premiums paid. The roll-up continues until either 10 years elapse, the benefit base hits the 250% ceiling, or you begin taking income. There is also a reset provision: if your account value ever exceeds the benefit base, the benefit base resets upward to match.

The 9% simple roll-up is a strong number for this product type. Whether it is worth 1.10% per year depends on when you start income and how long you live — the rider only pays out as a guaranteed withdrawal rate applied against the benefit base, not as a lump sum. The Inheritance Enhancer II death benefit rider offers a similar structure for legacy planning, but the two riders cannot be elected together, so buyers need to decide upfront which priority matters more.

The 7-year commitment here is real, and the MVA — Market Value Adjustment — makes it more consequential than a plain surrender charge. An MVA adjusts the amount you receive (up or down) when you take a surrender or excess withdrawal, based on changes in a designated interest rate index from when you issued the contract. In a rising interest rate environment, the MVA can increase your effective exit cost beyond the stated surrender charge. In a falling rate environment, it can reduce it. The key point is that you cannot precisely predict your total exit cost mid-contract.

Free withdrawals up to 10% of account value annually (years 2+) help buffer routine cash needs. RMDs attributable to this contract qualify through the ESP program without triggering surrender charges or MVA — an important feature for qualified money. The Extended Care and Terminal Illness waivers, included at no charge, also allow penalty-free access if qualifying medical situations arise (not available in Massachusetts). Even with those provisions, this contract should be funded with dollars you are confident you will not need beyond the free-withdrawal amount for seven years.

The base contract has no annual product fee. Rider fees are the primary ongoing cost: Income Ascender runs 1.10% currently (maximum 2.50%) and the Inheritance Enhancer II runs 1.15% currently (maximum 2.50%). Both are charged against account value based on the benefit base, so as the benefit base grows, so does the dollar cost of the rider.

The structural tradeoffs are worth naming directly. Cap rates limit upside in strong index years. The First Trust Barclays Edge Index carries embedded index construction costs that can affect how much raw index movement feeds into credited interest — this is not the same as holding the S&P 500 directly. The 7-year cap lock eliminates rate-reset risk but also eliminates any benefit from rising rates after issuance. The mutual exclusivity of the income and death benefit riders forces a binary choice at issue. And the Wells Fargo channel restriction means you cannot compare this product side-by-side across multiple carriers on your own — your access and pricing is anchored to that relationship.

Legal Entity: MassMutual Ascend Life Insurance Company

Parent: Massachusetts Mutual Life Insurance Company

AM Best Rating: A++

MassMutual Ascend is the annuity-focused subsidiary of Massachusetts Mutual Life, a mutual insurer with one of the longest track records and highest financial strength ratings in the industry. An A++ from AM Best is the top grade available, shared by only a handful of large insurers. That pedigree matters in an annuity context because the guarantees in this contract — the MGSV, the income rider's benefit base, the waiver provisions — are only as good as the carrier behind them.